Study identifies MET amplification as driver for some non-small cell lung cancers

(University of Colorado Anschutz Medical Campus) A study led by CU Cancer Center member D. Ross Camidge, MD, PhD, has helped define MET amplification as an actionable driver for some non-small cell lung cancers (NSCLC).
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news